{"id":54351,"date":"2023-02-28T23:04:32","date_gmt":"2023-02-28T22:04:32","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/"},"modified":"2023-02-28T23:04:32","modified_gmt":"2023-02-28T22:04:32","slug":"quanterix-to-present-at-cowens-43rd-annual-health-care-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/","title":{"rendered":"Quanterix to Present at Cowen\u2019s 43rd Annual Health Care Conference"},"content":{"rendered":"
\n

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation<\/a> (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Cowen\u2019s 43rd Annual Health Care Conference. Quanterix\u2019s session will take place on Tuesday, March 7, 2023, at 9:50 a.m. EST and will be made available to attendees and, via webcast, the general public. In addition to the session, Quanterix will also host one-on-one meetings with institutional investors during the conference.\n<\/p>\n

<\/a><\/p>\n

\nCowen\u2019s 43rd Annual Health Care Conference will take place March 6 – 8, 2023, at the Boston Marriott Copley Place in Boston, MA. The conference incorporates presentations, fireside chats and panel discussions hosted by members of the Cowen research team that focus on various aspects of the health care industry.\n<\/p>\n

\nWebcast Information
\n
<\/strong>To access the live audio webcast of Quanterix\u2019s presentation at the conference, please visit: https:\/\/wsw.com\/webcast\/cowen132\/qtrx\/2062158<\/a>. Quanterix\u2019s session will take place on Tuesday, March 7, 2023, at 9:50 a.m. EST.\n<\/p>\n

\nReplays of the presentation will be available for a limited period following the conference. The presentation will also be made available through the Investor Relations section of Quanterix\u2019s website.\n<\/p>\n

\nTo learn more about Quanterix, visit www.quanterix.com\/about<\/a>. To learn more about Quanterix\u2019s Simoa\u00ae technology, visit: https:\/\/www.quanterix.com\/technology<\/a>.\n<\/p>\n

\nAbout Quanterix
\n
<\/b>From discovery to diagnostics, Quanterix\u2019s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company\u2019s Simoa\u00ae <\/sup>technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Limit of Quantification (LoQ) of conventional analog methods. Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering research published in more than 2,000 peer-reviewed journals. Find additional information about the Billerica, Massachusetts-based company at https:\/\/www.quanterix.com<\/a> or follow us on Twitter<\/a> and LinkedIn<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:<\/b>
PAN Communications
\n
Maya Nimnicht
\n
510-334-6273
\n
quanterix@pancomm.com<\/a>\n<\/p>\n

\nInvestor Relations Contact:<\/b>
Amy Achorn
\n
(978) 488-1854
\n
ir@quanterix.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Cowen\u2019s 43rd Annual Health Care Conference. Quanterix\u2019s session will take place on Tuesday, March 7, 2023, at 9:50 a.m. EST and will be made available to attendees and, via … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54351","6":"format-standard","7":"category-industry"},"yoast_head":"\nQuanterix to Present at Cowen\u2019s 43rd Annual Health Care Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Quanterix to Present at Cowen\u2019s 43rd Annual Health Care Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Cowen\u2019s 43rd Annual Health Care Conference. Quanterix\u2019s session will take place on Tuesday, March 7, 2023, at 9:50 a.m. EST and will be made available to attendees and, via ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-28T22:04:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230228006341\/en\/778515\/21\/Quanterix_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Quanterix to Present at Cowen\u2019s 43rd Annual Health Care Conference\",\"datePublished\":\"2023-02-28T22:04:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\\\/\"},\"wordCount\":381,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230228006341\\\/en\\\/778515\\\/21\\\/Quanterix_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\\\/\",\"name\":\"Quanterix to Present at Cowen\u2019s 43rd Annual Health Care Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230228006341\\\/en\\\/778515\\\/21\\\/Quanterix_Logo.jpg\",\"datePublished\":\"2023-02-28T22:04:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230228006341\\\/en\\\/778515\\\/21\\\/Quanterix_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230228006341\\\/en\\\/778515\\\/21\\\/Quanterix_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Quanterix to Present at Cowen\u2019s 43rd Annual Health Care Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Quanterix to Present at Cowen\u2019s 43rd Annual Health Care Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/","og_locale":"en_US","og_type":"article","og_title":"Quanterix to Present at Cowen\u2019s 43rd Annual Health Care Conference - Pharma Trend","og_description":"BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Cowen\u2019s 43rd Annual Health Care Conference. Quanterix\u2019s session will take place on Tuesday, March 7, 2023, at 9:50 a.m. EST and will be made available to attendees and, via ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-28T22:04:32+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230228006341\/en\/778515\/21\/Quanterix_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Quanterix to Present at Cowen\u2019s 43rd Annual Health Care Conference","datePublished":"2023-02-28T22:04:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/"},"wordCount":381,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230228006341\/en\/778515\/21\/Quanterix_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/","url":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/","name":"Quanterix to Present at Cowen\u2019s 43rd Annual Health Care Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230228006341\/en\/778515\/21\/Quanterix_Logo.jpg","datePublished":"2023-02-28T22:04:32+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230228006341\/en\/778515\/21\/Quanterix_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230228006341\/en\/778515\/21\/Quanterix_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-present-at-cowens-43rd-annual-health-care-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Quanterix to Present at Cowen\u2019s 43rd Annual Health Care Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54351","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54351"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54351\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54351"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54351"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54351"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}